Eli Lilly ' s Alzheimer ' s Drug Shows Promise in Small Trial

Participants with the disease still declined, but much more slowly than those receiving a placebo, investigators say.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Alzheimer ' s Disease Drugs (Pharmaceuticals) Clinical Trials Research Eli Lilly and Company donanemab Source Type: news